Elysium Internet CEO Scott Gallagher commented, "We're pleased to have the opportunity to acquire such a high quality, one word, generic domain name as Chiropractor.net. With the Internet fast becoming the first stop for consumers doing research, a domain name such as this one will dramatically increase our exposure and naturally, our credibility among Internet users. We plan to launch our newest local Internet destination via the new domain as soon as possible. There are over 50,000 Chiropractors in the United States and more than half of them are self-employed. Compare that to only 17,000 Podiatrists in the entire country and you can see the opportunity is massive."
30% of the US population aged 18 and older have used a Chiropractor. According to the US Department of Labor the Job employment of Chiropractors is expected to increase 20% over the next ten years. Other studies suggest that more than 20 Million Americans will seek a Chiropractic care next year alone with costs related to lower back pain estimated to be $60 Billion.
Gallagher continued, "We're excited to be entering a market of this size where our performance-based local patient acquisition program will have such a major impact. We expect the new online destination to be launched within days and are in active negotiations with several highly experienced Chiropractors to serve as advisor's to Chiropractor.net."
What They Do: Elysium Internet (EYSM) is a publicly traded direct navigation Internet media Company. EYSM is focused on building targeted industry specific direct navigation based Internet directories and portals that generate significant traffic for the benefit of its advertising partners. The Company uses an ad based subscription model to generate the majority of its revenue.
Elysium operates through a network of 15 Internet Properties that generate millions of page view’s annually. Due to the extremely high quality of Elysium’s domain portfolio the vast amount of the traffic generated by the network properties is organic or non-paid traffic.
Boehringer Ingelheim Pharmaceuticals and Pfizer (NYSE: PFE) $18.22, jointly announced Thursday after market close that the U.S. Food and Drug Administration (FDA) has approved SPIRIVA HandiHaler (tiotropium bromide inhalation powder) for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD). SPIRIVA HandiHaler is already FDA-approved as a once-daily maintenance treatment for breathing problems associated with COPD, which includes chronic bronchitis, emphysema, or both.
What They Do: Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide.
NIKE, Inc. (NYSE: NKE) $63.25. Announced Thursday after market close financial results for its fiscal 2010 second quarter ended November 30, 2009. Second quarter revenues decreased 4 percent, from $4.6 billion last year to $4.4 billion in the current year; changes in currency exchange rates had a minimal impact on reported revenue results. Second quarter net income declined 4 percent, from $391 million last year to $375 million in the current year; diluted earnings per share decreased 5 percent to $0.76.
What They Do: NIKE, Inc. based near Beaverton, Oregon, is the world's leading designer, marketer and distributor of authentic athletic footwear, apparel, equipment and accessories for a wide variety of sports and fitness activities.
Oracle Corporation (Nasdaq: ORCL) $22.88. Announced Thursday after market close fiscal 2010 Q2 GAAP earnings per share of $0.29, up 15% compared to last year. Second quarter GAAP total revenues were up 4% to $5.9 billion, while quarterly GAAP net income was up 12% to $1.5 billion. GAAP new software license revenues were up 2% to $1.7 billion. GAAP software license updates and product support revenues were up 14% to $3.2 billion. GAAP operating income was up 10% to $2.2 billion and GAAP operating margin was up 200 basis points to 37%. GAAP operating cash flow on a trailing twelve-month basis was $8.7 billion, up 7%.
What They Do: Oracle is the world's largest business software company.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com/. To follow us on Twitter visit http://twitter.com/SmallCapReview. SmallCapReview has been compensated three thousand dollars by a third party Green Horseshoe for its services with regards to Elysium Internet.
